lymphocyte antigen 6 complex locus K
Lymphocyte antigen 6 complex locus K (61-84) is a synthetic peptide fragment corresponding to amino acids 61 through 84 of the Ly6K protein, a member of the Ly6/uPAR superfamily. This peptide is derived from a cell-surface glycoprotein implicated in immune cell signaling, cell adhesion, and tumor biology. Researchers value this segment for its ability to mimic a functional epitope within the native Ly6K protein, enabling the study of protein-protein interactions and molecular mechanisms underpinning immune responses and cancer progression. As a research tool, it serves as a model substrate for peptide-based assays and as a probe for elucidating Ly6K-related signaling events in various cellular contexts.
Epitope mapping: Utilization of the 61-84 peptide fragment is instrumental in epitope mapping studies, particularly for characterizing antibody recognition sites on Ly6K. By providing a defined linear sequence, the peptide enables researchers to delineate the precise amino acids involved in antibody binding, advancing the development of monoclonal antibodies and immunodiagnostic reagents. This approach supports the design of more selective and sensitive detection tools for Ly6K expression in immunological and oncological research.
Protein-protein interaction studies: The synthetic Ly6K (61-84) peptide serves as a valuable tool for dissecting molecular interactions between Ly6K and its binding partners. Through in vitro binding assays, pull-down experiments, or surface plasmon resonance analysis, investigators can use the peptide to identify and characterize proteins that specifically interact with this region of Ly6K. These studies contribute to a deeper understanding of Ly6K-mediated signaling pathways and their functional consequences in immune modulation and tumor cell biology.
Peptide-based assay development: As a well-defined sequence, the peptide is suitable for incorporation into various biochemical and immunological assays. Its use as an assay substrate or standard supports the quantification of Ly6K-specific antibodies or the activity of enzymes that target this region. Such applications are critical in the standardization of immunoassays, high-throughput screening platforms, and quality control procedures in research environments focused on immune markers and cell surface antigens.
Functional studies in cell signaling: Researchers employ the Ly6K (61-84) peptide to probe the functional relevance of this region in cell signaling processes. By introducing the peptide into cell-based systems, it is possible to study its effects on signaling cascades, cell adhesion properties, or immune cell activation. These experiments provide mechanistic insights into how specific Ly6K domains contribute to broader physiological or pathological outcomes, including immune cell communication and tumor progression.
Peptide synthesis and modification research: The Ly6K (61-84) fragment is also utilized as a model substrate in peptide synthesis and modification studies. Its moderate length and defined sequence make it suitable for exploring synthetic strategies, post-translational modifications, or conjugation techniques. Such research underpins the development of advanced peptide-based probes, therapeutic candidates, or bioconjugates for use in molecular biology and chemical biology investigations.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.